Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Ambrx Biopharma, Inc. has filed 77 SEC EDGAR filings since 25 Aug 2023

SEC filing history

Showing 26-50 of 77 matching filings.

Per page
25
Current page
2
SC 13G/A File 005-94206

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

AMENDMENT NO. 4

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC13G/A

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC 13G/A filing

Filing date
09 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94206

SC 13G/A

Filing date
05 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 000-56600

DFAN14A

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 000-56600

DEFM14A

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 000-56600

PREM14A

Filing date
19 Jan 2024
Reporting date
19 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 000-56600

DFAN14A

Filing date
09 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 000-56600

DFAN14A

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-56600

DEFA14A

Filing date
08 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
26 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
19 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Dec 2023
Reporting date
11 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Dec 2023
Reporting date
11 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Dec 2023
Reporting date
11 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
08 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
05 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-56600

144 filing

Filing date
01 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .